Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Therese Giuntoli"'
Autor:
Shunqiang Li, Dong Shen, Jieya Shao, Robert Crowder, Wenbin Liu, Aleix Prat, Xiaping He, Shuying Liu, Jeremy Hoog, Charles Lu, Li Ding, Obi L. Griffith, Christopher Miller, Dave Larson, Robert S. Fulton, Michelle Harrison, Tom Mooney, Joshua F. McMichael, Jingqin Luo, Yu Tao, Rodrigo Goncalves, Christopher Schlosberg, Jeffrey F. Hiken, Laila Saied, Cesar Sanchez, Therese Giuntoli, Caroline Bumb, Crystal Cooper, Robert T. Kitchens, Austin Lin, Chanpheng Phommaly, Sherri R. Davies, Jin Zhang, Megha Shyam Kavuri, Donna McEachern, Yi Yu Dong, Cynthia Ma, Timothy Pluard, Michael Naughton, Ron Bose, Rama Suresh, Reida McDowell, Loren Michel, Rebecca Aft, William Gillanders, Katherine DeSchryver, Richard K. Wilson, Shaomeng Wang, Gordon B. Mills, Ana Gonzalez-Angulo, John R. Edwards, Christopher Maher, Charles M. Perou, Elaine R. Mardis, Matthew J. Ellis
Publikováno v:
Cell Reports, Vol 4, Iss 6, Pp 1116-1130 (2013)
To characterize patient-derived xenografts (PDXs) for functional studies, we made whole-genome comparisons with originating breast cancers representative of the major intrinsic subtypes. Structural and copy number aberrations were found to be retaine
Externí odkaz:
https://doaj.org/article/1caf49e311cd490a9bd70c469f4ea5ca
Autor:
Kyongtae T. Bae, Gini F. Fleming, G. Thomas Budd, Paul K. Commean, Matthew J. Ellis, John A. Olson, Lyndsay A. Harris, Laura J. Esserman, George S. Leight, Therese Giuntoli, Jingqin Luo, Lisa A. Carey, Paul K. Marcom
Publikováno v:
Journal of the American College of Surgeons. 208:906-914
Background Neoadjuvant aromatase inhibitor therapy has been reported to improve surgical outcomes for postmenopausal women with clinical stage II or III hormone receptor-positive breast cancer. A multicenter phase II clinical trial was conducted to i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5bcab2d5e3d4eb4b554adb45b5b8197
https://doi.org/10.1016/j.jamcollsurg.2009.01.035
https://doi.org/10.1016/j.jamcollsurg.2009.01.035
Autor:
Austin Lin, Ron Bose, Matthew J. Ellis, Yiyu Dong, Charles M. Perou, Loren S. Michel, Rodrigo Franco Gonçalves, Chanpheng Phommaly, Ana M. Gonzalez-Angulo, Jingqin Luo, Rama Suresh, Caroline Bumb, Shuying Liu, Jeiya Shao, Rebecca Aft, Shunqiang Li, Timothy J. Pluard, Robert Crowder, Jeremy Hoog, Robert S. Fulton, Reida G. McDowell, Megha Shiyam Kavuri, Aleix Prat, Wenbin Liu, Crystal Cooper, Stephen N. Johnson, Yu Tao, Dong Shen, Therese Giuntoli, Elaine R. Mardis, Christopher J. Miller, Christopher A. Maher, Joshua F. McMichael, Li Lin, Shaomeng Wang, Katherine DeSchryver, Richard Wilson, Thomas B. Mooney, Li Ding, Michael Naughton, Gordon B. Mills, R.T. Kitchens, Dave Larson, Cynthia X. Ma
Publikováno v:
Cancer Research. 73:LB-265
Deeper understanding the mechanisms by which luminal-type breast cancer develops resistance to endocrine therapy and development of novel strategies to treat these patients requires model systems recapitulate human breast cancer as accurately as poss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8bfa384e30cab47493f3dc87161872ad
https://doi.org/10.1158/1538-7445.am2013-lb-265
https://doi.org/10.1158/1538-7445.am2013-lb-265
Autor:
Mathew J. Ellis, Michael Naughton, Feng Gao, Therese Giuntoli, Cynthia X. Ma, Reida G. McDowell, Y. H. Chia, Zhanfang Guo, Ling Lin, Mark A. Watson
Publikováno v:
Journal of Clinical Oncology. 27:11041-11041
11041 Background: Mutations in PIK3CA (encoding p110α catalytic subunit of phosphatidylinositol-3-kinase) are among the most common genetic events identified in breast cancer but the role of these mutations in determining the clinical course of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d281052edc6d4f6fc38c3b70b33304f3
https://doi.org/10.1200/jco.2009.27.15_suppl.11041
https://doi.org/10.1200/jco.2009.27.15_suppl.11041
Autor:
Shunqiang Li, Obi L. Griffith, Yiyu Dong, Jin Zhang, Laila Saied, Shuying Liu, Therese Giuntoli, Robert S. Fulton, Christopher G. Maher, Crystal Cooper, Jeremy Hoog, Wenbin Liu, Ron Bose, Austin Lin, Dave Larson, Robert J. Crowder, Chanpheng Phommaly, Xiaping He, Megha Shyam Kavuri, Rodrigo Franco Gonçalves, Yu Tao, Cynthia X. Ma, Caroline Bumb, Christopher A. Miller, Charles Lu, Ana M. Gonzalez-Angulo, John R. Edwards, Jeffrey F. Hiken, César Sánchez, Timothy J. Pluard, Dong Shen, Elaine R. Mardis, Michael Naughton, Li Ding, Gordon B. Mills, Rama Suresh, Reida G. McDowell, Joshua F. McMichael, R.T. Kitchens, Richard K. Wilson, Christopher E. Schlosberg, Sherri R. Davies, Jieya Shao, Aleix Prat, Loren S. Michel, Matthew J. Ellis, Rebecca Aft, Shaomeng Wang, Katherine DeSchryver, Jingqin Luo, Thomas B. Mooney, Michelle Harrison, Donna McEachern, Charles M. Perou, William E. Gillanders
Publikováno v:
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Cell Reports, Vol 4, Iss 6, Pp 1116-1130 (2013)
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Cell Reports, Vol 4, Iss 6, Pp 1116-1130 (2013)
SummaryTo characterize patient-derived xenografts (PDXs) for functional studies, we made whole-genome comparisons with originating breast cancers representative of the major intrinsic subtypes. Structural and copy number aberrations were found to be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cf172f7e68f3abac8e2b599a62c5260
http://hdl.handle.net/2445/102127
http://hdl.handle.net/2445/102127
